Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

M. Amin Arnaout, M.D.

Concepts

This page shows the publications M. Arnaout has written about Granulocytes.
Connection Strength

0.543
  1. Relative contribution of the leukocyte molecules Mo1, LFA-1, and p150,95 (LeuM5) in adhesion of granulocytes and monocytes to vascular endothelium is tissue- and stimulus-specific. J Cell Physiol. 1988 Nov; 137(2):305-9.
    View in: PubMed
    Score: 0.084
  2. Human complement receptor type 3. Methods Enzymol. 1987; 150:602-15.
    View in: PubMed
    Score: 0.074
  3. Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes. J Clin Invest. 1986 Aug; 78(2):597-601.
    View in: PubMed
    Score: 0.071
  4. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol). J Clin Invest. 1983 Jul; 72(1):171-9.
    View in: PubMed
    Score: 0.058
  5. Alternative complement pathway-dependent ingestion of fluolite particles by human granulocytes. J Immunol. 1981 Jul; 127(1):278-81.
    View in: PubMed
    Score: 0.050
  6. Cellular myosin heavy chain in human leukocytes: isolation of 5' cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation. Blood. 1991 Oct 01; 78(7):1826-33.
    View in: PubMed
    Score: 0.026
  7. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood. 1990 Mar 01; 75(5):1037-50.
    View in: PubMed
    Score: 0.023
  8. The relationship between CR3 deficiency and neutrophil actin assembly. Blood. 1989 May 15; 73(7):1973-9.
    View in: PubMed
    Score: 0.022
  9. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol. 1986 Nov 15; 137(10):3259-63.
    View in: PubMed
    Score: 0.018
  10. Mo1 surface glycoprotein: structure, function and clinical importance. Pathol Immunopathol Res. 1986; 5(3-5):371-83.
    View in: PubMed
    Score: 0.017
  11. Deficiency of two human leukocyte surface membrane glycoproteins (Mo1 and LFA-1). Fed Proc. 1985 Jul; 44(10):2664-70.
    View in: PubMed
    Score: 0.017
  12. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med. 1985 Feb 21; 312(8):457-62.
    View in: PubMed
    Score: 0.016
  13. Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mo1 deficiency. Effects of cell activation on Mo1/LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest. 1984 Oct; 74(4):1291-300.
    View in: PubMed
    Score: 0.016
  14. Deficiency of a surface membrane glycoprotein (Mo1) in man. J Clin Invest. 1984 Jan; 73(1):153-9.
    View in: PubMed
    Score: 0.015
  15. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG. J Immunol. 1983 Jul; 131(1):439-44.
    View in: PubMed
    Score: 0.014
  16. Complement (C3b) interaction with the human granulocyte receptor: correlation of binding of fluid-phase radiolabeled ligand with histaminase release. J Immunol. 1982 May; 128(5):2313-8.
    View in: PubMed
    Score: 0.013
  17. Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood. 1989 Jan; 73(1):131-6.
    View in: PubMed
    Score: 0.005
  18. p150/95, Third member of the LFA-1/CR3 polypeptide family identified by anti-Leu M5 monoclonal antibody. Eur J Immunol. 1985 Jul; 15(7):713-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.